Definitive Healthcare Net Worth
Definitive Healthcare Net Worth Breakdown | DH |
Definitive Healthcare Net Worth Analysis
Definitive Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Definitive Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Definitive Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Definitive Healthcare's net worth analysis. One common approach is to calculate Definitive Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Definitive Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Definitive Healthcare's net worth. This approach calculates the present value of Definitive Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Definitive Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Definitive Healthcare's net worth. This involves comparing Definitive Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Definitive Healthcare's net worth relative to its peers.
Enterprise Value |
|
To determine if Definitive Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Definitive Healthcare's net worth research are outlined below:
| Definitive Healthcare had very high historical volatility over the last 90 days | |
| Definitive Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 251.41 M. Annual Net Loss to common stockholders was (202.39 M) with gross profit of 216.68 M. | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: DH or FFIV Which Is the Better Value Stock Right Now |
Definitive Healthcare Quarterly Good Will |
|
Definitive Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Definitive Healthcare Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Definitive Healthcare Target Price Consensus
Definitive target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Definitive Healthcare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Buy |
Most Definitive analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Definitive stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Definitive Healthcare, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDefinitive Healthcare Target Price Projection
Definitive Healthcare's current and average target prices are 4.92 and 5.25, respectively. The current price of Definitive Healthcare is the price at which Definitive Healthcare Corp is currently trading. On the other hand, Definitive Healthcare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Definitive Healthcare Market Quote on 26th of February 2025
Target Price
Analyst Consensus On Definitive Healthcare Target Price
Know Definitive Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Definitive Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Definitive Healthcare Corp backward and forwards among themselves. Definitive Healthcare's institutional investor refers to the entity that pools money to purchase Definitive Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 775.6 K | Millennium Management Llc | 2024-12-31 | 772.9 K | New York State Common Retirement Fund | 2024-12-31 | 771.8 K | Boothbay Fund Management, Llc | 2024-09-30 | 724.5 K | D. E. Shaw & Co Lp | 2024-12-31 | 709.8 K | B. Riley Asset Management, Llc | 2024-12-31 | 677.9 K | Bank Of America Corp | 2024-12-31 | 617.5 K | Renaissance Technologies Corp | 2024-12-31 | 579.4 K | Citadel Advisors Llc | 2024-09-30 | 559.8 K | Advent International Lp | 2024-12-31 | 62.5 M | Irenic Capital Management Lp | 2024-12-31 | 7 M |
Follow Definitive Healthcare's market capitalization trends
The company currently falls under 'Small-Cap' category with a market capitalization of 574.15 M.Market Cap |
|
Project Definitive Healthcare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.43) | (0.45) | |
| Return On Capital Employed | (0.23) | (0.22) | |
| Return On Assets | (0.13) | (0.12) | |
| Return On Equity | (0.27) | (0.26) |
When accessing Definitive Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Definitive Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Definitive Healthcare's profitability and make more informed investment decisions.
Evaluate Definitive Healthcare's management efficiency
The current Return On Tangible Assets is estimated to decrease to -0.45. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.22. As of now, Definitive Healthcare's Intangibles To Total Assets are decreasing as compared to previous years. The Definitive Healthcare's current Debt To Assets is estimated to increase to 0.20, while Total Assets are projected to decrease to under 2.1 B. Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.57 | 9.81 | |
| Tangible Book Value Per Share | (1.59) | (1.67) | |
| Enterprise Value Over EBITDA | (6.00) | (5.70) | |
| Price Book Value Ratio | 1.50 | 1.42 | |
| Enterprise Value Multiple | (6.00) | (5.70) | |
| Price Fair Value | 1.50 | 1.42 | |
| Enterprise Value | 1.4 B | 1.4 B |
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 2.0354 | Revenue | Quarterly Revenue Growth (0.04) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Definitive Healthcare Corporate Filings
F4 | 19th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of February 2025 Other Reports | ViewVerify | |
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Definitive Healthcare Earnings Estimation Breakdown
The calculation of Definitive Healthcare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Definitive Healthcare is estimated to be 0.08595 with the future projection ranging from a low of 0.085 to a high of 0.09. Please be aware that this consensus of annual earnings estimates for Definitive Healthcare Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.09 Lowest | Expected EPS | 0.09 Highest |
Definitive Healthcare Earnings Projection Consensus
Suppose the current estimates of Definitive Healthcare's value are higher than the current market price of the Definitive Healthcare stock. In this case, investors may conclude that Definitive Healthcare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Definitive Healthcare's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 14 | 79.39% | 0.1 | 0.08595 | -3.09 |
Definitive Healthcare Earnings History
Earnings estimate consensus by Definitive Healthcare analysts from Wall Street is used by the market to judge Definitive Healthcare's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Definitive Healthcare's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Definitive Healthcare Quarterly Gross Profit |
|
Definitive Healthcare Earnings per Share Projection vs Actual
Actual Earning per Share of Definitive Healthcare refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Definitive Healthcare Corp predict the company's earnings will be in the future. The higher the earnings per share of Definitive Healthcare, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Definitive Healthcare Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Definitive Healthcare, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Definitive Healthcare should always be considered in relation to other companies to make a more educated investment decision.Definitive Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Definitive Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | 0.08 | 0.1 | 0.02 | 25 | ||
2024-08-05 | 2024-06-30 | 0.09 | 0.09 | 0.0 | 0 | ||
2024-05-07 | 2024-03-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2024-02-28 | 2023-12-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2023-11-02 | 2023-09-30 | 0.06 | 0.09 | 0.03 | 50 | ||
2023-08-14 | 2023-06-30 | 0.06 | 0.08 | 0.02 | 33 | ||
2023-05-04 | 2023-03-31 | 0.04 | 0.06 | 0.02 | 50 | ||
2023-02-23 | 2022-12-31 | 0.04 | 0.07 | 0.03 | 75 | ||
2022-11-03 | 2022-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2022-08-04 | 2022-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2022-05-05 | 2022-03-31 | 0.03 | 0.05 | 0.02 | 66 | ||
2022-02-23 | 2021-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2021-11-08 | 2021-09-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2021-09-16 | 2021-06-30 | 0 | 0.04 | 0.04 | 0 | ||
2021-06-30 | 2021-03-31 | 0 | -0.0974 | -0.0974 | 0 | ||
2021-03-31 | 2020-12-31 | 0 | -0.0974 | -0.0974 | 0 |
Definitive Healthcare Corporate Management
| Jon Maack | President | Profile | |
| Tom Penque | Chief Officer | Profile | |
| Matt Ruderman | Chief Secretary | Profile | |
| David Kronfeld | Chief Officer | Profile | |
| Richard CPA | Chief Officer | Profile | |
| Justin Steinman | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.